|5.22||+0.73 / +16.26%|
As of 3:59pm ET
|5.35||+0.13 / +2.49%|
The 1 analysts offering 12-month price forecasts for KaloBios Pharmaceuticals Inc have a median target of 64.00, with a high estimate of 64.00 and a low estimate of 64.00. The median estimate represents a +1,126.05% increase from the last price of 5.22.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.